Wei Wang
FDA investigator
Appears on 2 documents from 2022 to 2024, mostly at sites in Michigan. Most often cites control of microbiological contamination (21 CFR 211.113).
- 2
- Documents on file
- 3.0
- Observations per 483
- 2022
- First seen
- 2024
- Most recent
What they cite most
From 6 observations- 21 CFR 211.113Control of microbiological contamination2
- 21 CFR 211.188Batch production and control records1
- 21 CFR 211.192Production record review1
- 21 CFR 211.56Sanitation1
- 21 CFR 211.84Testing and approval or rejection of components, drug product containers, and closures1
Activity by year
2022: 1, 2024: 1
Where
Michigan 1 · Pennsylvania 1
Often inspects with
Is Wei Wang coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2024-09-19 | 483 Grand River Aseptic Manufacturing, Inc.Sep 19, 2024 · Grand Rapids, Michigan | Grand Rapids, Michigan | 2 | |
| 2022-11-16 | 483 Krystal Biotech, Inc.Nov 16, 2022 · Pittsburgh, Pennsylvania | Pittsburgh, Pennsylvania | 4 |
About this profile
What does Wei Wang inspect?
Wei Wang appears on 2 documents on file covering 2 sites, mostly in Michigan.
What do they cite most often?
21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.188 and 21 CFR 211.192.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Wei Wang is dated Sep 19, 2024.